Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes
- 1 February 1993
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 5 (1) , 17-26
- https://doi.org/10.1007/bf02260911
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- l‐Threodops increases extracellular norepinephrine levels in the brainNeurology, 1990
- Pharmacologic Treatment of Parkinsonian TremorArchives of Neurology, 1986
- Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Homovanillic Acid in the Cerebrospinal Fluid of Parkinsonian PatientsCanadian Journal of Neurological Sciences, 1983
- Regional distribution of catecholamines in monkey cerebral cortex, evidence for a dopaminergic innervation of the primate prefrontal cortexNeuroscience Letters, 1978
- Clinical Pharmacokinetics of Levodopa in Parkinson??s DiseaseClinical Pharmacokinetics, 1976
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973
- Central Monoamine Metabolism in Parkinson's DiseaseArchives of Neurology, 1972
- THE PROBENECID TEST IN PARKINSON'S DISEASEThe Lancet, 1972
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960